Showing results (901-910 of 1,022) with videos related to

Sort By:
Pageof 103
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|February 10, 2020
Knockdown of enhancer of rudimentary homolog inhibits proliferation and metastasis in ovarian cancer by regulating epithelial-mesenchymal transitionDan Zhang, Yi-Jing Chu, Ke-Juan Song, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|April 21, 2009
Rifampicin alters atorvastatin plasma concentration on the basis of SLCO1B1 521T>C polymorphismYi-Jing He, Wei Zhang, Yao Chen, et al.
Scientific Reports|September 25, 2015
Opposite Effects of M1 and M2 Macrophage Subtypes on Lung Cancer ProgressionAng Yuan, Yi-Jing Hsiao, Hsuan-Yu Chen, et al.
Plos One|May 25, 2012
A panel of serum microRNAs as specific biomarkers for diagnosis of compound- and herb-induced liver injury in ratsYu-Wen Su, Xi Chen, Zhen-Zhou Jiang, et al.
JCI Insight|May 3, 2022
Blimp-1 molds the epigenetic architecture of IL-21-mediated autoimmune diseases through an autoregulatory circuitYu-Wen Liu, Shin-Huei Fu, Ming-Wei Chien, et al.
Plos One|May 3, 2014
The prognostic value of altered eIF3a and its association with p27 in non-small cell lung cancersJie Shen, Ji-Ye Yin, Xiang-Ping Li, et al.
European Archives of Psychiatry and Clinical Neuroscience|July 20, 2021
Altered empathy-related resting-state functional connectivity in patients with bipolar disorderYun-Si Liang, Shu-Zhe Zhou, Yi-Jing Zhang, et al.
Frontiers in Psychiatry|February 10, 2023
The neural correlation of emotion recognition ability and depressive symptoms-evidence from the HCP databaseZe Yuan, Xiao Lin, Peng Li, et al.
Nature Communications|December 14, 2023
Structures revealing mechanisms of resistance and collateral sensitivity of Plasmodium falciparum to proteasome inhibitorsHao-Chi Hsu, Daqiang Li, Wenhu Zhan, et al.
Diabetology & Metabolic Syndrome|June 10, 2026
Real-world comparative outcomes of atorvastatin, rosuvastatin, and lovastatin-niacin fixed-dose combination in metabolic dysfunction-associated steatotic liver disease: hepatic, metabolic, and economic perspectivesYi Tseng Tsai, Sriyani Padmalatha Konara Mudiyanselage, Yi-Jing Tsai, et al.
Pageof 103